Thursday, August 03, 2023

Study reveals unexpected importance of the thymus in adults 


Peer-Reviewed Publication

MASSACHUSETTS GENERAL HOSPITAL




BOSTON – The thymus gland—which produces immune T cells before birth and during childhood— is often regarded as nonfunctional in adults, and it’s sometimes removed during cardiac surgery for easier access to the heart and major blood vessels. New research led by investigators at Massachusetts General Hospital (MGH) and published in the New England Journal of Medicine has uncovered evidence that the thymus is in fact critical for adult health generally and for preventing cancer and perhaps autoimmune disease.

To determine whether the thymus provides health benefits to adults, the team evaluated the risk of death, cancer, and autoimmune disease among 1,146 adults who had their thymus removed during surgery and among 1,146 demographically matched patients who underwent similar cardiothoracic surgery without thymectomy. The scientists also measured T cell production and blood levels of immune-related molecules in a subgroup of patients. 


Five years after surgery, 8.1% of patients who had a thymectomy died compared with 2.8% of those who did not have their thymus removed, equating to a 2.9-times higher risk of death. Also during that time, 7.4% of patients in the thymectomy group developed cancer compared with 3.7% of patients in the control group, for a 2.0-times higher risk.

“By studying people who had their thymus removed, we discovered that the thymus is absolutely required for health. If it isn’t there, people’s risk of dying and risk of cancer is at least double,” says senior author David T. Scadden, MD, director of the Center for Regenerative Medicine at MGH and co-director of the Harvard Stem Cell Institute. “This indicates that the consequences of thymus removal should be carefully considered when contemplating thymectomy.”

In an additional analysis involving all patients in the thymectomy group with more than five years of follow-up, the overall mortality rate was higher in the thymectomy group than in the general U.S. population (9.0% vs. 5.2%), as was mortality due to cancer (2.3% vs. 1.5%).

Although Scadden and his colleagues found that the risk of autoimmune disease did not differ substantially between the thymectomy and control groups as a whole in their study, they observed a difference when patients who had infection, cancer, or autoimmune disease before surgery were excluded from the analysis. After excluding these individuals, 12.3% of patients in the thymectomy group developed autoimmune disease compared with 7.9% in the control group, for a 1.5-times higher risk.

In the subgroup of patients in whom T cell production and immune-related molecules were measured (22 in the thymectomy group and 19 in the control group, with an average follow-up of 14.2 postoperative years), those who had undergone thymectomy had consistently lower production of new T cells than controls and higher levels of pro-inflammatory molecules in the blood. 


Scadden and his team now plan to assess how different levels of thymus function in adults affect individuals’ health. “We can test the relative vigor of the thymus and define whether the level of thymus activity, rather than just whether it is present, is associated with better health,” he says.

Additional co-authors include Kameron A. Kooshesh, MD, Brody H. Foy, DPhil, David B. Sykes, MD, PhD, and Karin Gustafsson, PhD.

This work was supported by the Tracey and Craig A. Huff Harvard Stem Cell Institute Research Support Fund, the Gerald and Darlene Jordan Professorship of Medicine, and a grant (U19AI149676, to Dr. Scadden) from the National Institutes of Health. Dr. Kooshesh received support from the American Society of Hematology. Dr. Gustafsson received support from the Swedish Research Council and the John S. Macdougall Jr. and Olive R. Macdougall Fund.


 

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In July 2022, Mass General was named #8 in the U.S. News & World Report list of "America’s Best Hospitals." MGH is a founding member of the Mass General Brigham healthcare system.

 

 

RACIST MEDICINE U$A

Study finds Black people less likely to be seen at memory clinic than white people


REDLINING

Where a person lives also linked to likelihood of being seen at clinic


Peer-Reviewed Publication

AMERICAN ACADEMY OF NEUROLOGY




MINNEAPOLIS – Black people and people living in less affluent neighborhoods—areas with higher poverty levels and fewer educational and employment opportunities— may be less likely to be seen at a memory care clinic compared to white people and people living in neighborhoods with fewer disadvantages, according to new research published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.  

“Our results are concerning, especially since these clinics are likely to be a major point of access for new Alzheimer’s treatments as they become available,” said study author Albert M. Lai, PhD, of Washington University in St. Louis in Missouri. “While we studied one memory clinic, if additional research finds similar disparities in other memory clinics, then these differences in access could worsen existing health care disparities.”

For the study, researchers looked at 4,824 people seen at a specialty memory care clinic at Washington University in St. Louis over 10 years. Of the total participants, 543, or 11%, were Black people and 4,281, or 89%, were non-Hispanic white people.

Researchers looked at the severity of dementia when people were first evaluated at the clinic.

Researchers used home addresses and a measure called the Area Deprivation Index to determine if each participant lived in an advantaged or disadvantaged neighborhood. The index incorporates information on the socioeconomic conditions of each neighborhood and its residents, ranking neighborhoods based on 17 indicators including income, employment, education and housing quality. Higher scores on this index indicate more neighborhood disadvantage.

People seen at the clinic were more likely to live in more advantaged neighborhoods, with patients having an average score of 45 on the area deprivation index, compared to an average score of 65 for the entire population in the service area.

Researchers found that Black people were underrepresented in the clinic. Black people made up 11% of those seen in the clinic, compared to 16% of those living in the clinic’s service area.

They also found that Black people were more likely to have more advanced dementia at their first visit to the memory clinic compared to white people. At their initial visit, 40% of Black people and 31% of white people had mild dementia or worse and 16% of Black people and 10% of white people had moderate or severe dementia.

After adjusting for age, sex, and area deprivation index, Black people were 59% more likely to have moderate to severe dementia at their initial evaluation than white people.

“This study provides additional motivation for addressing disparities that are likely to affect patient care,” Lai said. “Initiatives may include increased outreach to less affluent and more diverse neighborhoods, reducing requirements for scheduling an initial appointment, and hiring more doctors from diverse backgrounds.”

Lai noted that since research studies often recruit participants from large clinics, reduced use of these clinics by underserved groups could hamper efforts to make studies more inclusive.

A limitation of the study was that only one memory clinic was studied, so it is unknown whether similar disparities exist at other memory clinics.

The study was supported by Cure Alzheimer’s Fund.

Learn more about dementia at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on FacebookTwitter and Instagram.

When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy. 

For more information about the American Academy of Neurology, visit AAN.com or find us on FacebookTwitterInstagramLinkedIn and YouTube.

Study defines disparities in memory care


Provides baseline to measure progress toward racial equity in care for Alzheimer’s disease


Peer-Reviewed Publication

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE





Patients who live in less affluent neighborhoods and those from underrepresented racial or ethnic groups are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from Washington University School of Medicine in St. Louis indicates. Further, the research shows that Black people are more likely than white people to be diagnosed with dementia at a later, more advanced stage, which could contribute to inequities in access to new treatments.

The study appears Aug. 2 in the journal Neurology.

New medications to treat early-stage Alzheimer’s recently have emerged. Specifically, aducanumab (trade name Aduhelm) and lecanemab (trade name Leqembi) have been approved for certain patients with early Alzheimer’s disease, which makes the timely diagnosis of Alzheimer’s dementia crucial.

“Dementia care is going through a major transformation right now,” said Suzanne Schindler, MD, PhD, an associate professor of neurology and a co-author of the study. “With these new therapeutics, getting evaluated at a specialty clinic early on — when symptoms first develop — is going to be important in a way that it never was before so that eligible patients can have access to these treatments. Our study suggests that we must seek out ways to ensure that the distribution of these new treatments is equitable.”

The study was focused on the Washington University Memory Diagnostic Center in St. Louis. But identifying a local problem also can shine a light on the national and global problem of socioeconomic and racial disparities in health care and, in particular, Alzheimer’s care. This type of study provides a baseline for measuring the impact of efforts to reduce such disparities in the St. Louis region and more broadly, according to the researchers.

Various forms of dementia can be challenging to diagnose, and most primary care doctors don’t have the detailed information necessary to make, for example, a diagnosis of Alzheimer’s disease. Many such doctors refer patients who may be having memory problems to memory care clinics, where physicians specialize in the evaluation and management of Alzheimer’s disease and other types of cognitive impairment.

Many barriers can impede anyone with symptoms of Alzheimer’s from seeking care and a diagnosis: the requirements for insurance and a primary care provider’s referral, the necessity of a support person — usually a close family member — to accompany a patient to doctor’s visits and help describe their symptoms, the cultural expectations surrounding what constitutes “normal” memory loss, and the list goes on. Even if patients are able to check these boxes, they are often met with discouragingly long wait times for an appointment.

For many reasons, these barriers disproportionately impact individuals from underrepresented groups and people of lower socioeconomic status. This disparate access means that Black patients are less likely to receive a diagnosis of Alzheimer’s disease despite being twice as likely to develop dementia as white Americans.

The study utilized de-identified electronic health record data to compare the socioeconomic status of various neighborhoods where patients lived. Employing a sample of 4,824 Washington University patients from 2008-2018, the researchers evaluated how use of its memory clinic is associated with neighborhood-level measures of socioeconomic factors and race.

The researchers, including first author Abigail Lewis, an informatics doctoral student at Washington University, found that patients at the memory care clinic were more likely to reside in more affluent areas. Black patients were underrepresented, with 11% of clinic patients self-identifying as Black compared with 16% of residents in the area served by the clinic, according to census data. Further, the study showed that Black patients had more advanced dementia than white patients at their initial evaluations. At their first visits, 40% of Black patients and 31% of white patients met criteria for at least mild dementia, and 16% of Black patients and 10% of white patients had moderate or severe dementia.

“While we examined the situation with our patients here at Washington University, this disparity is likely to exist at other facilities nationwide,” said senior author Albert M. Lai, PhD, a professor of medicine in the Division of General Medical Sciences and chief research information officer. “We are hopeful this study can provide information needed to improve equity at Washington University and can provide a starting point to investigate these issues at other specialty memory care clinics across the country.”

These results were not surprising to Schindler or Lai, given that people with a lower socioeconomic status and from underrepresented groups are less likely than others to have health insurance and access to health care, among other barriers.

Still, Schindler said, “having the data that this study provides is compelling. Showing that you can see these disparities in data then gives you the ability to start working toward fixing it.”

Co-author Joyce (Joy) Balls-Berry, PhD, an associate professor of neurology, concurs with the importance of having these numbers and said they provide a renewed chance to consider health disparities moving forward.

Balls-Berry is deeply involved in efforts to address health disparities in memory care. She leads the Health Disparities and Equity Core, which was inaugurated by the Charles F. and Joanne Knight Alzheimer Disease Research Center (ADRC) in 2020 to incorporate principles of diversity, equity and inclusion into all aspects of the Knight ADRC’s work. She said that genuine community engagement is integral to these efforts. Community engagement offers a way to develop relationships with and trust within underrepresented and underresourced communities; it allows for a shared vision to be developed, and for communication between partners to be kept open in both directions.

“Moving forward, we have to be more agile,” Balls-Berry said. “We must continue to emphasize community engagement. I would like to find ways to move beyond having patients come to campus for their care. How do we bring clinical skills to spaces that aren’t clinics, and instead reach out to church communities or child-care facilities, for example, to meet people where they are? Toward better equity, I am interested in seeking ways to work with Dr. Lai’s team to build a process in the electronic health record to identify those patients that are in greatest need of receiving a referral and make sure they get it.”

The researchers suggested some possible interventions to investigate to determine if they move measures of equity in the right direction. Telehealth visits may expand access, as may increasing the number of doctors providing memory care. Another priority of the community is to increase the number of Black doctors providing care. Many times, according to Balls-Berry, patients express a desire to see health-care providers who share their life experiences in terms of gender and race.

“The next steps are always to do more research,” Lai added. “Data contained in the electronic health record is a powerful tool for identifying and monitoring disparities. We now have the opportunity to address them and measure our impact.”

Research and continued community engagement will become more important with each passing day, especially as, in Schindler’s words: “We are now entering this new era where there are treatments available that may have an actual disease-modifying effect on Alzheimer’s disease. This study provides strong evidence that we need change — we want to make our system more equitable in providing these new therapies to those who need them most.”

 

Bullying, suicidal thoughts linked to more frequent headaches in teens


Peer-Reviewed Publication

AMERICAN ACADEMY OF NEUROLOGY



MINNEAPOLIS – Teens who have been bullied by their peers, or who have considered or attempted suicide, may be more likely to have more frequent headaches than teens who have not experienced any of these problems, according to a study published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that bullying or thoughts of suicide cause headaches; it only shows an association.

“Headaches are a common problem for teenagers, but our study looked beyond the biological factors to also consider the psychological and social factors that are associated with headaches,” said study author Serena L. Orr, MD, MSc, of the University of Calgary in Canada. “Our findings suggest that bullying and attempting or considering suicide may be linked to frequent headaches in teenagers, independent of mood and anxiety disorders.”

The study involved more than 2.2 million teens with an average age of 14 years. Of the total participants, 0.5% self-reported being gender diverse, meaning being transgender or self-reporting as being gender diverse including being gender nonbinary.

Participants completed questionnaires about their headaches. They were asked if they had headaches in the past six months and at which frequency: rarely or never, about once a month, about once a week, more than once a week, or most days. Participants also answered questions regarding mental health including whether they had diagnosed mood or anxiety disorders, or both. They were asked if they were bullied in the past year and if they were, at what frequency. Lastly, they were asked whether they had suicidal thoughts in the past year and if they had any suicide attempts in their lifetime.

Of the participants, 11% reported having frequent, recurring headaches, defined as headaches occurring more than once a week. A total of 25% of the participants reported being victims of frequent overt bullying, including physical and verbal aggression, being called names or insulted, and being threatened virtually; and 17% reported being victims of frequent relational bullying, including having rumors spread about them, being excluded, and having harmful information posted about them on the internet. Also, 17% of participants reported considering or attempting suicide in their lifetime.

Researchers found that those who had frequent headaches were nearly three times more likely to experience bullying than their peers. Teenagers who had been bullied or had suicidal tendencies were nearly twice as likely to have frequent headaches as their peers, while those with mood and anxiety disorders were 50% and 74% more likely, respectively, to have frequent headaches than their peers.

Researchers found that 34% of teens with frequent headaches reported being victims of relational bullying at least once a month compared to 14% of teens who had headaches less than once a week. They also found that 34% of teens with frequent headaches had made one or more suicide attempts or had suicidal thoughts compared to 14% of teens with headaches less than once a week.

After adjusting for age and sex, researchers found that teenagers who reported being gender diverse were more likely to have frequent headaches. However, that link disappeared after adjusting for additional factors including being bullied or having a diagnosed mood or anxiety disorder.

“Though gender diverse teens appear to have a higher risk of frequent, recurring headaches, this association disappears after controlling for bullying, anxiety, depression, and suicidal tendencies, suggesting that perhaps gender diversity is not, in and of itself, related to frequent headaches, but that the psychosocial factors associated with it may explain this link,” Orr said. “This is important information because these factors are preventable and treatable, and as such, must be examined further.”

“These results should compel future research into interventions for bullying and a better understanding of how gender diverse youth are at a higher risk of headache disorders,” Orr said. “These findings should urge policymakers to increase efforts towards bullying prevention and should encourage doctors to screen children and teens with headache disorders for bullying and suicidal tendencies.”

A limitation of the study was that participants self-reported their headaches and other information and they may not have remembered all the information accurately.

Learn more about headaches at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on FacebookTwitter and Instagram.

When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

The American Academy of Neurology is the world’s largest association of neurologists and neuroscience professionals, with over 40,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.

For more information about the American Academy of Neurology, visit AAN.com or find us on FacebookTwitterInstagramLinkedIn and YouTube.

 

Public invited to follow Bering Land Bridge research project


Business Announcement

UNIVERSITY OF ALASKA FAIRBANKS




The public can follow a team of scientists aboard the research vessel Sikuliaq as they spend the month of August studying conditions that existed on the Bering Land Bridge during the last ice age.

The project, led by University of Alaska Fairbanks geology professor Sarah Fowell, will collect samples from beneath the sea floor to learn about the vegetation and climate of the region about 25,000 years ago.

The project team will share updates during their journey via several digital and social media channels:

Facebook

Instagram

Other platforms

There will also be opportunities to learn more about the project directly from the research team.

  • An in-person community event to discuss the project also will be held on Aug. 3 at 7 p.m. at Old St. Joe’s Church in Nome.

  • ship-to-shore live broadcast from Sikuliaq is scheduled on Aug. 24 at noon as part of the National Science Foundation’s “Live from the Arctic” series. The event is geared toward elementary and middle school students, but everyone is invited to join.

  • A discussion of the Bering Land Bridge research project was highlighted in a Strait Science lecture hosted by the UAF Northwest Campus in Nome on May 25. A video of the lecture is available online.

More information about the Bering Land Bridge research project is available through Bering Land Bridge National Preserve.

 

Workers are less productive and make more typos in the afternoon — especially on Fridays



An innovative new study from the Texas A&M School of Public Health offers objective insight on employee behavior and the potential benefits of flexible work arrangements.

Peer-Reviewed Publication

TEXAS A&M UNIVERSITY

1933


If there’s one thing most office workers can agree on, it’s that they tend to feel less productive toward the end of the day and the end of each work week. Now, a team of researchers at Texas A&M University has found objective evidence of this phenomenon in action.

A recent interdisciplinary study at the Texas A&M School of Public Health used a novel method of data collection to show that employees really are less active and more prone to mistakes on afternoons and Fridays, with Friday afternoon representing the lowest point of worker productivity.

The study, published in a recent issue of PLOS ONE, was authored by Drs. Taehyun Roh and Nishat Tasnim Hasan from the Department of Epidemiology and Biostatistics, along with Drs. Chukwuemeka Esomonu, Joseph Hendricks and Mark Benden from the Department of Environmental and Occupational Health, and graduate student Anisha Aggarwal from the Department of Health Behavior.

The researchers looked at the computer usage metrics of 789 in-office employees at a large energy company in Texas over a two-year period — January 1, 2017, to December 31, 2018.

“Most studies of worker productivity use employee self-reports, supervisory evaluations or wearable technology, but these can be subjective and invasive,” said Benden, professor and head of the Department of Environmental and Occupational Health. “Instead, we used computer usage metrics — things like typing speed, typing errors and mouse activity — to get objective, noninvasive data on computer work patterns.”

The team then compared computer usage patterns across different days of the week and times of the day to see what kinds of patterns emerged.

“We found that computer use increased during the week, then dropped significantly on Fridays,” said Roh, assistant professor in the Department of Epidemiology and Biostatistics. “People typed more words and had more mouse movement, mouse clicks and scrolls every day from Monday through Thursday, then less of this activity on Friday.”

In addition, Roh said, computer use decreased every afternoon, and especially on Friday afternoons.

“Employees were less active in the afternoons and made more typos in the afternoons—especially on Fridays,” he said. “This aligns with similar findings that the number of tasks workers complete increases steadily from Monday through Wednesday, then decreases on Thursday and Friday.”

What is the takeaway for employers? To start, flexible work arrangements, such as hybrid work or a four-day work week, may lead to happier and more productive employees.

As of May 2023, about 60 percent of full-time, paid workers in the United States worked entirely on-site. The remainder either worked remotely or had a hybrid arrangement that involved a combination of remote and on-site work. In addition, many employees have a compressed workweek in which they work longer hours, but on fewer days.

Other studies have found that those who work from home or work fewer days have less stress from commuting, workplace politics and other factors, and thus have more job satisfaction,” Benden said. “These arrangements give workers more time with their families and thus reduce work-family conflicts, and also give them more time for exercise and leisure activities, which have been shown to improve both physical and mental health.”

Not only that, but flexible work arrangements could boost the bottom line in other ways, such as reductions in electricity use, carbon footprint and carbon dioxide emissions.

“And now,” Benden said, “the findings from our study can further help business leaders as they identify strategies to optimize work performance and workplace sustainability.”

By Ann Kellett, Texas A&M University School of Public Health

 

Study shows care hotel model can successfully shorten hospital stays and reduce costs for non-emergency procedures


Reports and Proceedings

SOCIETY OF NEUROINTERVENTIONAL SURGERY



SAN DIEGO—Using a “care hotel” model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in the hospital, according to a study presented today at the Society of NeuroInterventional Surgery’s (SNIS) 20th Annual Meeting.

 

Rising health care costs pose a significant financial burden across the U.S., especially since the start of the COVID-19 pandemic. Researchers at the Mayo Clinic Florida recently tried a new approach: moving patients to a “care hotel” after surgery. In the study, “The Safety and Feasibility of a Care Hotel Model in Elective Neuroendovascular Interventions—A Single Institutional Experience,” Mayo Clinic researchers reviewed data for 78 patients who were slated to have elective neuroendovascular interventions, including aneurysms. In the study, 42 patients were enrolled and received same-day surgery and were discharged to a “care hotel” instead of being admitted to the hospital after their procedures.

 

While staying at the “care hotel,” patients were monitored by nurses and had immediate access to the on-campus hospital if needed. All patients were discharged home the following day, except for one person with lingering numbness who was hospitalized for two days. Based on cost saving calculations, this resulted in saving $1,500 to $2,600 per procedure. One hospital bed was also saved for other potential patients who required hospitalization.

 

The study authors found this fast-track model to be safe, feasible, and cost-effective for qualified patients.

 

“Using a care hotel can help carefully selected patients reduce their time in the hospital after non-emergency procedures while maintaining high-quality care and outcomes,” said Dr. Rabih Tawk, a neurointerventional surgeon at the Mayo Clinic in Jacksonville, Florida. “It’s a promising model, as they can save time and money while recovering in a more comfortable place, and the hospitals can keep more beds available for emergency cases.”

 

To receive a copy of this abstract or to speak with the study authors, please contact Camille Jewell at cjewell@vancomm.com or 202-248-5460.

 

About the Society of NeuroInterventional Surgery

The Society of NeuroInterventional Surgery (SNIS) is a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery through research, standard-setting, and education and advocacy to provide the highest quality of patient care in diagnosing and treating diseases of the brain, spine, head, and neck. Visit www.snisonline.org and follow us on Twitter (@SNISinfo) and Facebook (@SNISOnline).

###

 


New HIV drug formulation could improve treatment outcomes for children worldwide


Worldwide CU Anschutz researchers helped evaluate a new drug formulation for children with HIV


Peer-Reviewed Publication

UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS




Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).

The study was published today in The Lancet HIV and reveals a new dispersible formulation and an immediate-release tablet containing three medications - dolutegravir, abacavir and lamivudine - in a single fixed dose combination (FDC) formulation is safe, well tolerated, and effective for treating children with HIV. The dosing based on the concentrations of each medication in the blood was also appropriate.

“This is the first FDC containing dolutegravir that can be used for children from 13 to 88 pounds,” said Kristina Brooks, PharmD, an assistant professor in the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz. “HIV treatment in children has historically been challenging as it requires the use of multiple tablets and liquids that don’t always taste the best, and can be challenging to administer.”

Dolutegravir, abacavir and lamivudine have been shown to be safe and effective worldwide to treat HIV. Brooks and Jennifer Kiser, PharmD, PhD, worked with a team of investigators through the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network to look at both an existing immediate release tablet and a new formulation of dispersible release tablets containing all three drugs to see if it would yield the same positive results they have seen in adults and adolescents.

“57 children were enrolled across five weight bands in four countries, of which 54 children used the new combination over 24 weeks. In 98 percent of the participants who continued the study drug, the amount of HIV in the blood remained suppressed below 200 copies/mL at week 24. The safety, tolerability, and effectiveness of these formulations look very positive,” Brooks said.

Child-friendly FDC formulations for HIV are limited. Brooks said this new formulation could help enable continuity of treatment, improve treatment outcomes and make it easier for caregivers responsible for dispensing the drugs. This study also helped support recent labeling updates by the U.S. Food and Drug Administration to expand the use of this formulation to children aged at least 3 months and weighing at least 13 pounds.

There are currently two million children living with HIV across the globe. Only 52 percent are on therapy, and despite making up only four percent of the worldwide HIV population, children account for 15 percent of AIDS-related deaths. Studies like this are vital to improve these outcomes and to make medication more accessible around the world.

“We must continue to pursue child-friendly treatment options to overcome the current global disparity in treatment outcomes between children and adults,” Brooks said.

Some of the children who were in the initial trial are still on the new drug formulation through an open access program. The longer-term safety, tolerability, and effectiveness through 12 months of treatment is under analysis now and will be reported separately.

About the IMPAACT Network

Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Mental Health (NIMH), all components of the National Institutes of Health (NIH), under Award Numbers UM1AI068632-15 (IMPAACT LOC), UM1AI068616-15 (IMPAACT SDMC) and UM1AI106716-15 (IMPAACT LC), and by NICHD contract number HHSN275201800001I. Additional funding support and study product was provided by ViiV Healthcare. 

About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals - UCHealth University of Colorado Hospital and Children's Hospital Colorado - that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, the University of Colorado Anschutz Medical Campus delivers life-changing treatments, patient care and professional training and conducts world-renowned research fueled by over $690 million in research grants. For more information, visit www.cuanschutz.edu.

 

People with a hepatitis C cure still face substantial risk of death


Findings highlight importance of ongoing post-cure support


Peer-Reviewed Publication

BMJ




Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population - between 3 and 14 times higher depending on liver disease stage, finds the largest study of its kind published by The BMJ today.

Based on data from more than 20,000 patients with a hepatitis C cure, the results show that drug and liver-related causes of death were the main drivers of excess deaths - and highlight the importance of continued support to fully realise the benefits of a hepatitis C cure.

Hepatitis C is a virus that can infect the liver which, if left untreated, can cause serious and potentially life-threatening liver damage over many years.

Historically, hepatitis C was treated with interferon-based therapy, which was often ineffective. But in 2011, new medications called direct acting antivirals (DAA) were developed. Now more than 95% of patients treated with DAAs achieve a “virological cure” and have a significantly lower risk of death than untreated patients.

Yet the question of what prognosis cured patients can expect compared with the general population remains the subject of debate.

To explore this further, a team of UK and Canadian researchers set out to measure mortality rates in individuals with a hepatitis C cure and assess how these rates compare with the general population.

They analysed data from three population studies carried out in British Columbia (Canada), Scotland and England involving 21,790 individuals who achieved a hepatitis C cure between 2014 and 2019. 

Individuals were grouped by the severity of liver disease at the time of cure: pre-cirrhosis (British Columbia and Scotland studies only), compensated cirrhosis, and end stage liver disease.

Data were then linked to national medical registries and several causes of death were examined, including liver cancer, liver failure, drug-related death, external causes (mainly accidents, homicides and suicides) and diseases of the circulatory system, over an average follow-up period of 2-4 years.

Most participants did not have cirrhosis at cure. The average age of pre-cirrhosis patients in Scotland was 44 years and 56 years in British Columbia, and males outnumbered females across all studies and disease severity groups (65-75%). 

A total of 1,572 (7%) of participants died during follow-up. The leading causes of death were drug related (24%), liver failure (18%) and liver cancer (16%). 

After taking account of age, death rates were considerably higher than the general population across all disease severity groups and settings. 

For example, in Scotland, the rate for all patients was 4.5 times greater than the general population (442 deaths observed versus 98 expected), while in British Columbia, rates were 3.9 times greater (821 deaths observed versus 209 expected). 

Rates also increased appreciably with liver disease severity. For example, in British Columbia rates were 3 times higher in people without cirrhosis and 14 times higher for patients with end stage liver disease.

For patients without cirrhosis, the leading cause of excess death was drug related, whereas in patients with cirrhosis, the two leading drivers were liver cancer and liver failure.

Across all disease stages and settings, older age, recent substance use, alcohol use and pre-existing conditions (comorbidities) were associated with higher death rates.

These are observational findings and the researchers acknowledge that they may not apply to all settings, particularly where injecting drug use is not the dominant mode of hepatitis C transmission.

However, this is the largest and most representative study performed to date and the researchers say their results “show unequivocally that cured patients continue to face substantial mortality rates, driven by liver and drug-related causes.”

As such, they highlight the importance of establishing robust post-cure follow-up pathways, as well as services and interventions to prevent drug and alcohol-related harms, to fully realise the benefits of a hepatitis C cure.

[Ends]